Hemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026

November 5, 2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai- 400001 Scrip No. 543916 Subject: Intimation of the Board Meeting Dear Sir/Madam, Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please take note that a Meeting of the Board of Directors of the Company will be held on Saturday, November 14, 2026 to consider and approve, inter-alia, the Unaudited Financial Results (standalone and consolidated) of the Company for the half year ended September 30, 2026. Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Company's Securities is already closed from October 01, 2026, for all Designated Persons of the Company and will open 48 hours after the aforesaid Un- audited Financial Results are declared to the Stock Exchange. Kindly take same on records. Thanking You, Yours faithfully, For Hemant Surgical Industries Limited Hanskumar Shamji Shah Managing Director DIN: 00215972 Email id: hanskumar@hemantsurgical.com 502,5th Floor, Esctacy, JSD Road, City of Joy Commercial, Mulund (W), Mumbai-400 080. Tel. : +91-22-2591 2747 Email: info@hemantsurgical.com, sales@hemantsurgical.com, Web : www.hemantsurgical.com CIN: L33110MH1989PLC051133